Recall report: Novo Nordisk recalls samples of multiple insulin products after storage screw-up

Five different insulin drugs have been recalled by Novo Nordisk after the company says the samples were stored at the wrong temperature.

The recall affects 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy. The recall only impacts samples, and not product that’s been distributed to pharmacies or mail-order services, the FDA said.